Safety notes: BPC-157 isnt FDA-approved for human use (its sold as a research peptide), so long-term safety data is limited
From there, it was found that treatment with BPC 157 in the experimental groups led to consistent improvement in motor function in comparison to the control groups
However, a newer approach peptide -based regenerative support is shifting attention toward repair, recovery, and restoration
Contraindications Hypersensitivity to the components of the drug
Kang et al., 2018), it is possible that the BPC 157 therapeutic effect may also be related to improvements in abdominal wall compliance
These include: Oxidative stress: One of the more recent studies on DSIP, from 2011, concluded that the peptide has a strong antioxidant effect owing to an ability to activate the (rat) bodys natural mechanisms against oxidative stress.21 Edema (swelling via fluid buildup): Again in rats, a 1992 study suggested that DSIP may have an antiedematic effect related to the activation of the GABAergic system and inhibition of serotonin, noradrenaline, and histamine systems.22 Convulsions: Two rodent studies in the 1990s support DSIPs use as an anticonvulsant
